Our in vitro results advise that EAM-2201 ought to be examined regarding opportunity in vivo pharmacokinetic drug–drug interactions caused by time-dependent inhibition of CYP2C8, CYP2C9, CYP2C19 and CYP3A4 functions and aggressive inhibition of UGT1A3 action. Dose-reaction effects of subcutaneously administered AM-2201 on overall body temperatures and catalepsy scores in… obs) https://hubbardg050pfs3.wikigop.com/user